BLACK FRIDAY

ADVFN

Celebrating 25 years Est 1999-2024

Save up to 65%* for Small Cap Pro

1 year 40%, 2 years 50% and *3 years 65%

*Across 3 years $2158.56 only $755.50

ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,987.37
      0.30%
      US Tech 100
      20,282.40
      0.25%
      Dow Jones
      44,736.57
      0.99%
      Brent Oil
      72.635
      -2.86%
      Bitcoin
      93,708.85
      -4.44%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Australia
      5. ASX

      6. Avecho Biotechnology Limited (AVE) Quote

      Avecho Biotechnology Limited

      Avecho Biotechnology Limited (AVE)

      AVE SA
      0.002
      0.00
      (0.00%)
      Closed November 25 12:00AM
      Delayed by 20 minutes

      Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

      Premium

      Key stats and details

      Current Price
      0.002
      Bid
      0.002
      Ask
      0.003
      Volume
      0.00
      0.00 Day's Range 0.00
      0.001 52 Week Range 0.005
      Market Cap
      6.339M
      Previous Close
      0.002
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      3,471,903
      Shares Outstanding
      3,169,297,013
      Dividend Yield
      -
      PE Ratio
      0.00
      Earnings Per Share (EPS)
      -0
      Revenue
      1.59M
      Net Profit
      -3.44M

      About Avecho Biotechnology Limited

      Sector
      Pharmaceutical Preparations
      Industry
      Financial Services Div'd
      Website
      www.avecho.com.au
      Headquarters
      Melbourne, Victoria, Aus
      Founded
      1992
      Avecho Biotechnology Limited is listed in the Pharmaceutical Preparations sector of the Australian Stock Exchange with ticker AVE. The last closing price for Avecho Biotechnology was AUD0. Over the last year, Avecho Biotechnology shares have traded in a share price range of AUD 0.001 to AUD 0.005.

      Avecho Biotechnology currently has 3,169,297,013 shares outstanding. The market capitalization of Avecho Biotechnology is AUD6.34 million. Avecho Biotechnology has a price to earnings ratio (PE ratio) of 0.00.

      Ask ADVFN Intelligence (AI)

      AVE Latest News

      More News

      Aventis Named to List of Top 100 Companies for Working Mothers

      Aventis Named to List of Top 100 Companies for Working Mothers Receives Honors Three Years Running BRIDGEWATER, N.J., Sept. 21 /PRNewswire-FirstCall/ -- For the third year in a row, Aventis has...

      September 21 2004
      PR Newswire (US)

      The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity

      The sanofi-aventis Group Thanks Its Team Members and Shareholders and Launches Its New Visual Identity PARIS, Sept. 16 /PRNewswire-FirstCall/ -- The sanofi-aventis Group launched an advertising...

      September 16 2004
      PR Newswire (US)

      Aventis to Move Forward With Reissuance Process for Contested Lovenox Patent

      Aventis to Move Forward With Reissuance Process for Contested Lovenox Patent BRIDGEWATER, N.J., July 27 /PRNewswire-FirstCall/ -- Aventis announced today that it received a second rejection from...

      July 27 2004
      PR Newswire (US)

      New Data Confirm Lovenox(R) is an Effective Antithrombotic for Treatment of Acute Coronary Syndromes

      New Data Confirm Lovenox(R) is an Effective Antithrombotic for Treatment of Acute Coronary Syndromes SYNERGY, A to Z and a Systematic Overview of Six Randomized Trials Published in JAMA...

      July 07 2004
      PR Newswire (US)

      Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers

      Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers PARIS, June 23 /PRNewswire-FirstCall/ -- On June 22, 2004, the Autorite des marches financiers (AMF) -- the French stock market...

      June 23 2004
      PR Newswire (US)

      Sanofi-Synthelabo's Offer for Aventis; Adjustment of Offer Terms on Approval of Aventis Dividend

      Sanofi-Synthelabo's Offer for Aventis; Adjustment of Offer Terms on Approval of Aventis Dividend PARIS, June 14 /PRNewswire-FirstCall/ -- Sanofi-Synthelabo (PARIS: SAN, NYSE: SNY) announces that...

      June 14 2004
      PR Newswire (US)

      Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers

      Sanofi-Synthelabo's Offer for Aventis Expiration Date of Offers PARIS, June 1 /PRNewswire-FirstCall/ -- On June 1, 2004, the Autorite des marches financiers (AMF) -- the French stock market...

      June 01 2004
      PR Newswire (US)

      Aventis and U.S. NIH Enter Into Pandemic Influenza Vaccine Agreement

      Aventis and U.S. NIH Enter Into Pandemic Influenza Vaccine Agreement World's Largest Vaccine Developer to Produce Investigational Vaccine for Clinical Trials SWIFTWATER, Pa., May 27...

      May 27 2004
      PR Newswire (US)

      Sanofi-Synthelabo's Offer for Aventis U.S. Offer Extended to Wednesday, June 30, 2004

      Sanofi-Synthelabo's Offer for Aventis U.S. Offer Extended to Wednesday, June 30, 2004 PARIS, May 26 /PRNewswire-FirstCall/ -- Sanofi-Synthelabo (PARIS: SAN, NYSE: SNY) announces that pending the...

      May 26 2004
      PR Newswire (US)

      Data Show Once-Daily Alvesco(R) (ciclesonide) Has No Effect on HPA-Axis Function in Asthma Patients

      Data Show Once-Daily Alvesco(R) (ciclesonide) Has No Effect on HPA-Axis Function in Asthma Patients Findings Presented Suggest Minimal Potential for Adverse Effects Commonly Seen With Inhaled...

      May 23 2004
      PR Newswire (US)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.001-33.33333333330.0030.0030.0021777180.00275617DE
      4-0.001-33.33333333330.0030.0030.0028006070.00236012DE
      12-0.0005-200.00250.0030.00134719030.00210654DE
      26-0.001-33.33333333330.0030.0040.00122233350.00228149DE
      52-0.0015-42.85714285710.00350.0050.00131665100.00333596DE
      156-0.014-87.50.0160.0230.00121015900.00606205DE
      260-0.002-500.0040.0450.00128967580.01521613DE

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      1ADAdAlta Limited
      AUD 0.017
      (0.00%)
      		0
      14DO1414 Degrees Limited
      AUD 0.008
      (0.00%)
      		0
      14DN1414 Degrees Limited
      AUD 0.00
      (0.00%)
      		0
      14D1414 Degrees Limited
      AUD 0.037
      (0.00%)
      		0
      13S13 Seeds Limited
       0.00
      (0.00%)
      		0
      1ADAdAlta Limited
      AUD 0.017
      (0.00%)
      		0
      14DO1414 Degrees Limited
      AUD 0.008
      (0.00%)
      		0
      14DN1414 Degrees Limited
      AUD 0.00
      (0.00%)
      		0
      14D1414 Degrees Limited
      AUD 0.037
      (0.00%)
      		0
      13S13 Seeds Limited
       0.00
      (0.00%)
      		0
      AMCAmcor PLC
      AUD 16.229
      (0.00%)
      		563.93k
      BHPBHP Group Limited
      AUD 40.407
      (0.00%)
      		100k
      VULVulcan Energy Resources Limited
      AUD 8.091
      (0.00%)
      		38k
      ADTAdriatic Metals Plc
      AUD 4.066
      (0.00%)
      		29.82k
      AAIAlcoa Corp
      AUD 72.276
      (0.00%)
      		13k

      Discussion

      View Full Feed
      tapioca tapioca 4 minutes ago
      Down again today ,,, and 25%. ??
      CRCW
      underpar71 underpar71 5 minutes ago
      Wrong. 150 plus 60 days clock off is 210, we are over that. Complexity is irrelevant. High quality applications get done in under a year.
      NWBO
      mrwilson31 mrwilson31 5 minutes ago
      Love this
      XCRT
      CommodityCoverage CommodityCoverage 5 minutes ago
      Recent insider buying by Morgan Lekstrom, President of NexGold Mining (NEXG.v, NXGCF), underscores the growing confidence in the company’s transformative merger with Signal Gold: https://x.com/StckMasterFlash/status/1861166594983940551

      The merger creates a combined entity with 4.7 mil
      NXGCF
      Lazarus Lazarus 6 minutes ago
      Between you and the SEC the markets are a safer place :)
      My update as we close out 2024

      Our youngest son got married a couple of weeks ago - entire family in attendance --- 6 kids and 14 grandkids
      One son announced another child on the way.
      My wife and I recently
      northam43 northam43 8 minutes ago
      Report # 7 UPRO/SPXS Signals. Today UPRO Sell Signal was confirmed. I am selling only positions with a 10% or more gain. The Weekly W-E-2 is projected to end by 12/27/24. So I will hold UPRO positions with less than 10% gain and add positions when Buy Signals become active.

      https://in
      SPXS
      walterc walterc 8 minutes ago
      MSCI small cap index?
      LWLG
      Major Profits Major Profits 8 minutes ago
      "OTC companies especially Pinks SURVIVE off selling Stock until they are revenue Producing."
      Did you bother to read the report? Here:
      VI. RECOMMENDATIONS AND NEXT STEPS

      ...The only access to working capital or any kind that NSAV appears to have is the sale of shares on t
      NSAV
      martyDg martyDg 9 minutes ago
      The MHRA should not take a full year. With the current standard being a 150-day assessment period for high-quality applications, a decision should be reached within 5 months. However, additional time may be needed depending on the complexity of the application; the review process may take longer, bu
      NWBO
      nagoya1 nagoya1 9 minutes ago
      Thinking of your superior GSE acumen.
      https://www.youtube.com/watch?v=Ee_uujKuJMI
      FNMA
      Investor2014 Investor2014 9 minutes ago
      Matt Nachrab, the Hosai of $SAVA.
      SAVA
      65actual 65actual 9 minutes ago
      Happy to see Benoit on the run and his complicit fraudsters finally exposed.
      UAMA
      lighter than AIR lighter than AIR 9 minutes ago
      Nahhh, you just handle the truth about this scam.
      BMXI
      PennyMillions852 PennyMillions852 9 minutes ago
      Everyone claiming to be buying these dips is lying straight to your face while they either sell or lose confidence altogether. But I can assure you, they are not buying as they claim. It’s like the boy crying wolf…..🗑️🗑️🗑️
      IGPK
      firebag1 firebag1 9 minutes ago
      if true thats a biggy, time will tell good luck
      RDAR
      biotechinvestor1 biotechinvestor1 9 minutes ago
      It takes a bit of time for people to understand what is going on. Halozyme's projected EPS through 2030 is intact regardless of 1) whether halozyme wins its patent infringement lawsuit against Alteogen or 2) whether Merck can successfully apeal halo's MDASE patent.

      Why? MDASE is/would
      HALO
      lighter than AIR lighter than AIR 10 minutes ago
      I’ve been completely honest.
      BMXI
      Zorch305 Zorch305 10 minutes ago
      https://x.com/Telvantis/status/1854189794462470518
      RDAR
      I-Glow I-Glow 10 minutes ago
      I would never invest in a OTC stock - the OTC is for trading not investing.

      AVVH is down 98% since it was hijacked.

      I did tell my friend to buy at $0.0005 and get out at $0.09 but he procrastinated and didn't get between $0.075 and $0.05. I knew that AVVH was going to b
      AVVH
      gdog gdog 10 minutes ago
      I'm going to ad one more thing concering my ban on the bounce thread then will let it go, I have been in touch with
      amitauman the CEO of IHUB and he told me he will look into it, we'll see if he's a man of his word or not, I believe he is..
      NLST
      oldmystic oldmystic 10 minutes ago
      Journal of Alzheimer's Disease
      https://www.j-alz.com/
      AVXL
      Eagle1 Eagle1 11 minutes ago
      No body is talking about all the MIRROR Trades. Check the tape.

      MM BS causing uninformed to panic. Typical.

      Lots of this volume today was total BS MM Algo's JMHO
      GDVM
      Moonboy1 Moonboy1 11 minutes ago
      Rock on! I guess we got that wick today. Can she hold
      QUBT

      Your Recent History

      ASX
      AVE
      Avecho Biotechnology
      Delayed Upgrade Clock